XDWH:F:F-Xtrackers (IE) Public Limited Company - Xtrackers MSCI World Health Care UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 51.37

Change

0.00 (0.00)%

Market Cap

USD 2.60B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-29 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.35 (+1.32%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

N/A

USD 112.00B
SXR8:F iShares Core S&P 500 UCITS ETF..

+0.86 (+0.15%)

USD 98.90B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.70 (+1.29%)

USD 92.14B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 57.35B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.19 (+1.28%)

USD 53.27B
VUSA:F Vanguard Funds Public Limited ..

+0.31 (+0.30%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.38 (+0.37%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

-0.01 (-0.14%)

USD 40.47B
0ZC:F Zscaler Inc

+2.84 (+1.65%)

USD 37.92B

ETFs Containing XDWH:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.60% 64% D 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.60% 64% D 65% D
Trailing 12 Months  
Capital Gain 19.04% 51% F 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.04% 51% F 59% D-
Trailing 5 Years  
Capital Gain 64.44% 80% B- 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 64.44% 80% B- 75% C
Average Annual (5 Year Horizon)  
Capital Gain 10.17% 73% C 68% D+
Dividend Return 10.17% 70% C- 62% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.95% 70% C- 91% A-
Risk Adjusted Return 113.62% 99% N/A 98% N/A
Market Capitalization 2.60B 89% A- 70% C-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike